Allogene Therapeutics Eulerpool News

Allogene Therapeutics Eulerpool News

Allogene Therapeutics Stock News

Allogene Therapeutics is being monitored by journalists and investors worldwide. We gather the latest Allogene Therapeutics news here.

• September 27 ·

  GuruFocus
  Allogene Therapeutics (ALLO) Stock Jumps by 5.15%
• September 26 ·

  Yahoo
  Allogene Therapeutics to Present Pre-Clinical Data Highlighting the Potential of ALLO-329, an Allogeneic CD19/CD70 Dual CAR T for the Treatment of Autoimmune Diseases, at the American College of Rheumatology (ACR) Convergence
• September 26 ·

  Thefly.com
  Allogene to present pre-clinical data for next-gen AlloCAR T candidate
• September 18 ·

  Yahoo
  IGM Biosciences (IGMS) Surges 11.6%: Is This an Indication of Further Gains?
• September 14 ·

  Yahoo
  Allogene Therapeutics, Inc. (ALLO): Short Seller Sentiment is Bearish on This Cancer Stock
• September 13 ·

  Thefly.com
  Biotech Alert: Searches spiking for these stocks today
• September 6 ·

  Yahoo
  Allogene Therapeutics (ALLO) Up 6.4% Since Last Earnings Report: Can It Continue?
• August 30 ·

  SeekingAlpha
  Cellectis: Cheap With Promising But Speculative Cancer Therapies
• August 27 ·

  SeekingAlpha
  Allogene Therapeutics: Cema-Cel Promising Among Innovative CAR T-Cell Therapies
• August 15 ·

  TipRanks
  Buy Rating Affirmed for Allogene Therapeutics on Strong Financials and Positive Pipeline Prospects